You have free access to this content

Hepatology

Cover image for Hepatology

September 2013

Volume 58, Issue 3

Pages 839–1195

  1. Editorials

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Steatohepatitis and Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury and Regeneration
    10. Liver Biology and Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Perspectives in Hepatology
    14. Correspondence
    15. Correction
    16. Retraction
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
    4. You have free access to this content
    5. You have free access to this content
  2. Viral Hepatitis

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Steatohepatitis and Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury and Regeneration
    10. Liver Biology and Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Perspectives in Hepatology
    14. Correspondence
    15. Correction
    16. Retraction
    1. You have free access to this content
      Hepatitis B testing and access to care among racial and ethnic minorities in selected communities across the United States, 2009-2010 (pages 856–862)

      Dale J. Hu, Jian Xing, Rania A. Tohme, Youlian Liao, Henry Pollack, John W. Ward and Scott D. Holmberg

      Version of Record online: 6 AUG 2013 | DOI: 10.1002/hep.26286

    2. You have free access to this content
      Up-regulation of circulating miR-20a is correlated with hepatitis C virus-mediated liver disease progression (pages 863–871)

      Shubham Shrivastava, Jessica Petrone, Robert Steele, Georg M. Lauer, Adrian M. Di Bisceglie and Ratna B. Ray

      Version of Record online: 23 JUL 2013 | DOI: 10.1002/hep.26296

    3. You have free access to this content
      Response-guided peginterferon therapy in hepatitis B e antigen-positive chronic hepatitis B using serum hepatitis B surface antigen levels (pages 872–880)

      Milan J. Sonneveld, Bettina E. Hansen, Teerha Piratvisuth, Ji-Dong Jia, Stefan Zeuzem, Edward Gane, Yun-Fan Liaw, Qing Xie, E. Jenny Heathcote, Henry L.-Y. Chan and Harry L.A. Janssen

      Version of Record online: 29 JUL 2013 | DOI: 10.1002/hep.26436

    4. You have full text access to this OnlineOpen article
      Synergism of tapasin and human leukocyte antigens in resolving hepatitis C virus infection (pages 881–889)

      Shirin Ashraf, Katja Nitschke, Usama M. Warshow, Collin R. Brooks, Arthur Y. Kim, Georg M. Lauer, Theresa J. Hydes, Matthew E. Cramp, Graeme Alexander, Ann-Margaret Little, Robert Thimme, Christoph Neumann-Haefelin and Salim I. Khakoo

      Version of Record online: 29 JUL 2013 | DOI: 10.1002/hep.26415

    5. You have free access to this content
      Characterization of the dynamics of hepatitis B virus resistance to adefovir by ultra-deep pyrosequencing (pages 890–901)

      Christophe Rodriguez, Stéphane Chevaliez, Paul Bensadoun and Jean-Michel Pawlotsky

      Version of Record online: 30 JUL 2013 | DOI: 10.1002/hep.26383

    6. You have free access to this content
      Resistance analysis of hepatitis C virus genotype 1 prior treatment null responders receiving daclatasvir and asunaprevir (pages 902–911)

      Fiona McPhee, Dennis Hernandez, Fei Yu, Joseph Ueland, Aaron Monikowski, Arlene Carifa, Paul Falk, Chunfu Wang, Robert Fridell, Timothy Eley, Nannan Zhou and David Gardiner

      Version of Record online: 16 JUL 2013 | DOI: 10.1002/hep.26388

    7. You have free access to this content
      High incidence of treatment-induced and vaccine-escape hepatitis B virus mutants among human immunodeficiency virus/hepatitis B–infected patients (pages 912–922)

      Karine Lacombe, Anders Boyd, Fabien Lavocat, Christian Pichoud, Joel Gozlan, Patrick Miailhes, Caroline Lascoux-Combe, Guy Vernet, Pierre-Marie Girard and Fabien Zoulim

      Version of Record online: 25 JUN 2013 | DOI: 10.1002/hep.26374

    8. You have free access to this content
    9. You have free access to this content
      An alpaca nanobody inhibits hepatitis C virus entry and cell-to-cell transmission (pages 932–939)

      Alexander W. Tarr, Pierre Lafaye, Luke Meredith, Laurence Damier-Piolle, Richard A. Urbanowicz, Annalisa Meola, Jean-Luc Jestin, Richard J. P. Brown, Jane A. McKeating, Felix A. Rey, Jonathan K. Ball and Thomas Krey

      Version of Record online: 30 JUL 2013 | DOI: 10.1002/hep.26430

    10. You have free access to this content
  3. Steatohepatitis/Metabolic Liver Disease

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Steatohepatitis and Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury and Regeneration
    10. Liver Biology and Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Perspectives in Hepatology
    14. Correspondence
    15. Correction
    16. Retraction
    1. You have full text access to this OnlineOpen article
      Clinical effect and safety profile of recombinant human lysosomal acid lipase in patients With cholesteryl ester storage disease (pages 950–957)

      Manisha Balwani, Catherine Breen, Gregory M. Enns, Patrick B. Deegan, Tomas Honzík, Simon Jones, John P. Kane, Vera Malinova, Reena Sharma, Eveline O. Stock, Vassili Valayannopoulos, J. Edmond Wraith, Jennifer Burg, Stephen Eckert, Eugene Schneider and Anthony G. Quinn

      Version of Record online: 28 MAR 2013 | DOI: 10.1002/hep.26289

  4. Steatohepatitis and Metabolic Liver Disease

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Steatohepatitis and Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury and Regeneration
    10. Liver Biology and Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Perspectives in Hepatology
    14. Correspondence
    15. Correction
    16. Retraction
    1. You have free access to this content
      Frequency of the cholesteryl ester storage disease common LIPA E8SJM mutation (c.894G>A) in various racial and ethnic groups (pages 958–965)

      Stuart A. Scott, Benny Liu, Irina Nazarenko, Suparna Martis, Julia Kozlitina, Yao Yang, Charina Ramirez, Yumi Kasai, Tommy Hyatt, Inga Peter and Robert J. Desnick

      Version of Record online: 29 JUL 2013 | DOI: 10.1002/hep.26327

    2. You have free access to this content
      Characterization of european ancestry nonalcoholic fatty liver disease-associated variants in individuals of african and hispanic descent (pages 966–975)

      Nicholette D. Palmer, Solomon K. Musani, Laura M. Yerges-Armstrong, Mary F. Feitosa, Lawrence F. Bielak, Ruben Hernaez, Bratati Kahali, J. Jeffrey Carr, Tamara B. Harris, Min A. Jhun, Sharon L.R. Kardia, Carl D. Langefeld, Thomas H. Mosley Jr, Jill M. Norris, Albert V. Smith, Herman A. Taylor, Lynne E. Wagenknecht, Jiankang Liu, Ingrid B. Borecki, Patricia A. Peyser and Elizabeth K. Speliotes

      Version of Record online: 16 JUL 2013 | DOI: 10.1002/hep.26440

    3. You have free access to this content
      Desmosterol in human nonalcoholic steatohepatitis (pages 976–982)

      Marko Simonen, Ville Männistö, Joel Leppänen, Dorota Kaminska, Vesa Kärjä, Sari Venesmaa, Pirjo Käkelä, Johanna Kuusisto, Helena Gylling, Markku Laakso and Jussi Pihlajamäki

      Version of Record online: 29 JUL 2013 | DOI: 10.1002/hep.26342

  5. Hepatobiliary Malignancies

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Steatohepatitis and Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury and Regeneration
    10. Liver Biology and Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Perspectives in Hepatology
    14. Correspondence
    15. Correction
    16. Retraction
    1. You have free access to this content
      Imaging mass spectrometry reveals modified forms of histone H4 as new biomarkers of microvascular invasion in hepatocellular carcinomas (pages 983–994)

      Nicolas Poté, Theodore Alexandrov, Julie Le Faouder, Samira Laouirem, Thibaut Léger, Mouniya Mebarki, Jacques Belghiti, Jean-Michel Camadro, Pierre Bedossa and Valérie Paradis

      Version of Record online: 30 JUL 2013 | DOI: 10.1002/hep.26433

    2. You have free access to this content
      Hedgehog signaling pathway regulates autophagy in human hepatocellular carcinoma cells (pages 995–1010)

      Ying Wang, Chang Han, Lu Lu, Susan Magliato and Tong Wu

      Version of Record online: 30 JUL 2013 | DOI: 10.1002/hep.26394

    3. You have free access to this content
      Mutual interaction between YAP and CREB promotes tumorigenesis in liver cancer (pages 1011–1020)

      Jiayi Wang, Lifang Ma, Wenhao Weng, Yongxia Qiao, Yue Zhang, Jiangtu He, Hongmei Wang, Weifan Xiao, Lanlan Li, Qinghua Chu, Qiuhui Pan, Yongchun Yu and Fenyong Sun

      Version of Record online: 16 JUL 2013 | DOI: 10.1002/hep.26420

    4. You have free access to this content
      Inflammation-induced hepatocellular carcinoma is dependent on CCR5 in mice (pages 1021–1030)

      Neta Barashi, Ido D. Weiss, Ori Wald, Hanna Wald, Katia Beider, Michal Abraham, Shiri Klein, Daniel Goldenberg, Jonathan Axelrod, Eli Pikarsky, Rinat Abramovitch, Evelyne Zeira, Eithan Galun and Amnon Peled

      Version of Record online: 12 JUL 2013 | DOI: 10.1002/hep.26403

    5. You have free access to this content
      Adjuvant gemcitabine therapy improves survival in a locally induced, R0-resectable model of metastatic intrahepatic cholangiocarcinoma (pages 1031–1041)

      Engin Gürlevik, Bettina Fleischmann-Mundt, Nina Armbrecht, Thomas Longerich, Norman Woller, Arnold Kloos, Dirk Hoffmann, Axel Schambach, Thomas C. Wirth, Michael P. Manns, Lars Zender, Stefan Kubicka and Florian Kühnel

      Version of Record online: 29 JUL 2013 | DOI: 10.1002/hep.26468

    6. You have free access to this content
      Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma (pages 1042–1053)

      Massimiliano Cadamuro, Giorgia Nardo, Stefano Indraccolo, Luigi Dall'Olmo, Luisa Sambado, Lidia Moserle, Irene Franceschet, Michele Colledan, Marco Massani, Tommaso Stecca, Nicolò Bassi, Stuart Morton, Carlo Spirli, Romina Fiorotto, Luca Fabris and Mario Strazzabosco

      Version of Record online: 22 JUL 2013 | DOI: 10.1002/hep.26384

    7. You have free access to this content
      Sirtuin-6–dependent genetic and epigenetic alterations are associated with poor clinical outcome in hepatocellular carcinoma patients (pages 1054–1064)

      Jens U. Marquardt, Kerstin Fischer, Katharina Baus, Anubha Kashyap, Shengyun Ma, Markus Krupp, Matthias Linke, Andreas Teufel, Ulrich Zechner, Dennis Strand, Snorri S. Thorgeirsson, Peter R. Galle and Susanne Strand

      Version of Record online: 30 JUL 2013 | DOI: 10.1002/hep.26413

    8. You have free access to this content
      Expression of SLC22A1 variants may affect the response of hepatocellular carcinoma and cholangiocarcinoma to sorafenib (pages 1065–1073)

      Elisa Herraez, Elisa Lozano, Rocio I.R. Macias, Javier Vaquero, Luis Bujanda, Jesus M. Banales, Jose J.G. Marin and Oscar Briz

      Version of Record online: 30 JUL 2013 | DOI: 10.1002/hep.26425

  6. Autoimmune, Cholestatic and Biliary Disease

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Steatohepatitis and Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury and Regeneration
    10. Liver Biology and Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Perspectives in Hepatology
    14. Correspondence
    15. Correction
    16. Retraction
    1. You have free access to this content
      Genome-wide association analysis in Primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4 (pages 1074–1083)

      David Ellinghaus, Trine Folseraas, Kristian Holm, Eva Ellinghaus, Espen Melum, Tobias Balschun, Jon K. Laerdahl, Alexey Shiryaev, Daniel N. Gotthardt, Tobias J. Weismüller, Christoph Schramm, Michael Wittig, Annika Bergquist, Einar Björnsson, Hanns-Ulrich Marschall, Morten Vatn, Andreas Teufel, Christian Rust, Christian Gieger, H-Erich Wichmann, Heiko Runz, Martina Sterneck, Christian Rupp, Felix Braun, Rinse K. Weersma, Cisca Wijmenga, Cyriel Y. Ponsioen, Christopher G. Mathew, Paul Rutgeerts, Séverine Vermeire, Erik Schrumpf, Johannes R. Hov, Michael P. Manns, Kirsten M. Boberg, Stefan Schreiber, Andre Franke and Tom H. Karlsen

      Version of Record online: 17 JAN 2013 | DOI: 10.1002/hep.25977

    2. You have free access to this content
      Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis (pages 1084–1093)

      Janosch Katt, Dorothee Schwinge, Tanja Schoknecht, Alexander Quaas, Ingo Sobottka, Eike Burandt, Christoph Becker, Markus F. Neurath, Ansgar W. Lohse, Johannes Herkel and Christoph Schramm

      Version of Record online: 30 JUL 2013 | DOI: 10.1002/hep.26447

    3. You have free access to this content
      Clonality, activated antigen-specific CD8+ T cells, and development of autoimmune cholangitis in dnTGFβRII mice (pages 1094–1104)

      Kazuhito Kawata, Guo-Xiang Yang, Yugo Ando, Hajime Tanaka, Weici Zhang, Yoshimasa Kobayashi, Koichi Tsuneyama, Patrick S.C. Leung, Zhe-Xiong Lian, William M. Ridgway, Aftab A. Ansari, Xiao-Song He and M. Eric Gershwin

      Version of Record online: 24 JUL 2013 | DOI: 10.1002/hep.26418

    4. You have free access to this content
      Genotype-phenotype relationships in the low-phospholipid-associated cholelithiasis syndrome: A study of 156 consecutive patients (pages 1105–1110)

      Raoul Poupon, Olivier Rosmorduc, Pierre Yves Boëlle, Yves Chrétien, Christophe Corpechot, Olivier Chazouillères, Chantal Housset and Véronique Barbu

      Version of Record online: 29 JUL 2013 | DOI: 10.1002/hep.26424

    5. You have free access to this content
  7. Liver Failure/Cirrhosis/Portal Hypertension

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Steatohepatitis and Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury and Regeneration
    10. Liver Biology and Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Perspectives in Hepatology
    14. Correspondence
    15. Correction
    16. Retraction
    1. You have free access to this content
      The Stroop smartphone application is a short and valid method to screen for minimal hepatic encephalopathy (pages 1122–1132)

      Jasmohan S. Bajaj, Leroy R. Thacker, Douglas M. Heuman, Michael Fuchs, Richard K. Sterling, Arun J. Sanyal, Puneet Puri, Mohammad S. Siddiqui, Richard T. Stravitz, Iliana Bouneva, Velimir Luketic, Nicole Noble, Melanie B. White, Pamela Monteith, Ariel Unser and James B. Wade

      Version of Record online: 23 MAY 2013 | DOI: 10.1002/hep.26309

  8. Liver Injury and Regeneration

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Steatohepatitis and Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury and Regeneration
    10. Liver Biology and Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Perspectives in Hepatology
    14. Correspondence
    15. Correction
    16. Retraction
    1. You have free access to this content
      Adipose tissue-derived stem cells as a regenerative therapy for a mouse steatohepatitis-induced cirrhosis model (pages 1133–1142)

      Akihiro Seki, Yoshio Sakai, Takuya Komura, Alessandro Nasti, Keiko Yoshida, Mami Higashimoto, Masao Honda, Soichiro Usui, Masayuki Takamura, Toshinari Takamura, Takahiro Ochiya, Kengo Furuichi, Takashi Wada and Shuichi Kaneko

      Version of Record online: 24 JUL 2013 | DOI: 10.1002/hep.26470

    2. You have free access to this content
      The degree of liver injury determines the role of p21 in liver regeneration and hepatocarcinogenesis in mice (pages 1143–1152)

      Laura Elisa Buitrago-Molina, Silke Marhenke, Thomas Longerich, Amar Deep Sharma, Aristeidis E. Boukouris, Robert Geffers, Bruno Guigas, Michael P. Manns and Arndt Vogel

      Version of Record online: 7 AUG 2013 | DOI: 10.1002/hep.26412

  9. Liver Biology and Pathobiology

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Steatohepatitis and Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury and Regeneration
    10. Liver Biology and Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Perspectives in Hepatology
    14. Correspondence
    15. Correction
    16. Retraction
    1. You have free access to this content
      miR-148a plays a pivotal role in the liver by promoting the hepatospecific phenotype and suppressing the invasiveness of transformed cells (pages 1153–1165)

      Luc Gailhouste, Laura Gomez-Santos, Keitaro Hagiwara, Izuho Hatada, Noriyuki Kitagawa, Kazushi Kawaharada, Muriel Thirion, Nobuyoshi Kosaka, Ryou-u Takahashi, Tatsuhiro Shibata, Atsushi Miyajima and Takahiro Ochiya

      Version of Record online: 30 JUL 2013 | DOI: 10.1002/hep.26422

  10. Reviews

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Steatohepatitis and Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury and Regeneration
    10. Liver Biology and Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Perspectives in Hepatology
    14. Correspondence
    15. Correction
    16. Retraction
    1. You have free access to this content
  11. Hepatology Elsewhere

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Steatohepatitis and Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury and Regeneration
    10. Liver Biology and Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Perspectives in Hepatology
    14. Correspondence
    15. Correction
    16. Retraction
    1. You have free access to this content
      Anticoagulation in cirrhosis: Ready … set … wait! (pages 1175–1176)

      Susana Seijo and Juan Carlos Garcia-Pagan

      Version of Record online: 29 JUL 2013 | DOI: 10.1002/hep.26503

    2. You have free access to this content
  12. Clinical Perspectives in Hepatology

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Steatohepatitis and Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury and Regeneration
    10. Liver Biology and Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Perspectives in Hepatology
    14. Correspondence
    15. Correction
    16. Retraction
    1. You have free access to this content
  13. Correspondence

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Steatohepatitis and Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury and Regeneration
    10. Liver Biology and Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Perspectives in Hepatology
    14. Correspondence
    15. Correction
    16. Retraction
    1. You have free access to this content
      Retinoids counteract insulin resistance and liver steatosis: What's the potential mechanism? (page 1185)

      Nadia Panera, Sara Ceccarelli, Cristiano De Stefanis, Valerio Nobili and Anna Alisi

      Version of Record online: 14 MAR 2013 | DOI: 10.1002/hep.26213

    2. You have free access to this content
      Reply (page 1186)

      Hiroyuki Tsuchiya, Kentaro Kogure and Goshi Shiota

      Version of Record online: 10 JUL 2013 | DOI: 10.1002/hep.26217

    3. You have free access to this content
    4. You have free access to this content
      Reply (pages 1187–1188)

      Charalambos G. Antoniades and Julia Wendon

      Version of Record online: 29 JUL 2013 | DOI: 10.1002/hep.26281

    5. You have free access to this content
      Notch2 signaling and undifferentiated liver cancers: Evidence of hepatic stem/progenitor cell origin (page 1188)

      Vincenzo Cardinale, Guido Carpino, Lola M. Reid, Eugenio Gaudio and Domenico Alvaro

      Version of Record online: 29 JUL 2013 | DOI: 10.1002/hep.26280

    6. You have free access to this content
      Prognostic significance of von willebrand factor in cirrhosis: A possible mechanism (page 1189)

      Chundamannil E. Eapen, Joshua E. Elias, Ian Mackie and Elwyn Elias

      Version of Record online: 29 JUL 2013 | DOI: 10.1002/hep.26282

    7. You have free access to this content
      Reply (pages 1189–1190)

      Monika Ferlitsch, Markus Peck-Radosavljevic and Arnulf Ferlitsch

      Version of Record online: 29 JUL 2013 | DOI: 10.1002/hep.26288

    8. You have free access to this content
    9. You have free access to this content
      Reply (page 1191)

      Norah Terrault, Jennifer Dodge and Miriam Alter

      Version of Record online: 1 AUG 2013 | DOI: 10.1002/hep.26324

    10. You have free access to this content
    11. You have free access to this content
      Reply (page 1192)

      Eun Sung Park and Ju-Seog Lee

      Version of Record online: 1 AUG 2013 | DOI: 10.1002/hep.26347

  14. Correction

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Steatohepatitis and Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury and Regeneration
    10. Liver Biology and Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Perspectives in Hepatology
    14. Correspondence
    15. Correction
    16. Retraction
    1. You have free access to this content
      Flipping the switch (page 1193)

      Version of Record online: 31 JUL 2013 | DOI: 10.1002/hep.26457

      This article corrects:

      Flipping the Switch1

      Vol. 57, Issue 2, 851–852, Version of Record online: 5 FEB 2013

    2. You have free access to this content
  15. Retraction

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Steatohepatitis and Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury and Regeneration
    10. Liver Biology and Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Perspectives in Hepatology
    14. Correspondence
    15. Correction
    16. Retraction
    1. You have free access to this content
    2. You have free access to this content

SEARCH

SEARCH BY CITATION